Read More Pharma Industry News Mylan launches Hulio, a biosimilar to Humira, across major European markets Mylan has officially launched Hulio, its biosimilar to AbbVie’s Humira (adalimumab), across major European markets. This launch follows… bypharmanewsdailyOctober 22, 2018
